tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

KPTI Stock Latest News

Karyopharm sees Q4 revenue ~$30M, consensus $38.2M
The FlyKaryopharm sees Q4 revenue ~$30M, consensus $38.2M
5d ago
KPTI
Karyopharm Appoints Lori Macomber as New CFO
PremiumCompany Announcements
Karyopharm Appoints Lori Macomber as New CFO
16d ago
8K
KPTI
Karyopharm appoints Lori Macomber as CFO
PremiumThe Fly
Karyopharm appoints Lori Macomber as CFO
16d ago
KPTI
Karyopharm Engages with FDA on Cancer Trial Plans
PremiumCompany Announcements
Karyopharm Engages with FDA on Cancer Trial Plans
2M ago
8K
KPTI
Karyopharm reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Karyopharm reports inducement grants under Nasdaq listing rule
2M ago
KPTI
Karyopharm Therapeutics Appoints New Chief Accounting Officer
PremiumCompany AnnouncementsKaryopharm Therapeutics Appoints New Chief Accounting Officer
2M ago
8K
KPTI
Karyopharm appoints Kristin Abate as Chief Accounting Officer
Premium
The Fly
Karyopharm appoints Kristin Abate as Chief Accounting Officer
2M ago
KPTI
Karyopharm price target raised to $5 from $4 at Piper Sandler
Premium
The Fly
Karyopharm price target raised to $5 from $4 at Piper Sandler
2M ago
KPTI
Karyopharm Therapeutics Inc. Reports Q3 2024 Earnings
PremiumCompany Announcements
Karyopharm Therapeutics Inc. Reports Q3 2024 Earnings
2M ago
KPTI
Karyopharm reports Q3 EPS (26c), consensus (27c)
PremiumThe Fly
Karyopharm reports Q3 EPS (26c), consensus (27c)
2M ago
KPTI
Karyopharm narrows 2024 revenue view to $145M-$155M from $145M-$160M
PremiumThe Fly
Karyopharm narrows 2024 revenue view to $145M-$155M from $145M-$160M
2M ago
KPTI
Karyopharm Therapeutics Updates Phase 3 SENTRY Trial
PremiumCompany Announcements
Karyopharm Therapeutics Updates Phase 3 SENTRY Trial
3M ago
8K
KPTI
Karyopharm changes endpoint in Phase 3 trial of selinexor in myelofibrosis
PremiumThe FlyKaryopharm changes endpoint in Phase 3 trial of selinexor in myelofibrosis
3M ago
KPTI
KPTI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KPTI Earnings this Week: How Will it Perform?
3M ago
KPTI
Michael Mason Resigns as CFO of Karyopharm Therapeutics
Premium
Company Announcements
Michael Mason Resigns as CFO of Karyopharm Therapeutics
5M ago
8K
KPTI
Karyopharm price target lowered to $5 from $8 at Baird
PremiumThe Fly
Karyopharm price target lowered to $5 from $8 at Baird
5M ago
KPTI
Karyopharm narrows 2024 revenue view to $145M-$160M from $140M-$160M
PremiumThe Fly
Karyopharm narrows 2024 revenue view to $145M-$160M from $140M-$160M
5M ago
KPTI
Karyopharm reports Q2 EPS (20c), consensus (30c)
PremiumThe Fly
Karyopharm reports Q2 EPS (20c), consensus (30c)
5M ago
KPTI
Karyopharm Therapeutics INC (KPTI) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Karyopharm Therapeutics INC (KPTI) Q2 Earnings Cheat Sheet
6M ago
KPTI
Karyopharm granted FDA orphan designation in Ewing sarcoma
PremiumThe FlyKaryopharm granted FDA orphan designation in Ewing sarcoma
6M ago
KPTI
Karyopharm’s padnarsertib granted FDA orphan designation in sarcoma treatment
Premium
The Fly
Karyopharm’s padnarsertib granted FDA orphan designation in sarcoma treatment
6M ago
KPTI
Karyopharm price target lowered to $7 from $8 at H.C. Wainwright
Premium
The Fly
Karyopharm price target lowered to $7 from $8 at H.C. Wainwright
7M ago
KPTI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >